Meeting Starts In:


Enhance Speed, Purity & Scalability of Your Process Development & Manufacturing to Improve Functionality, Efficacy & Approval Rate of mRNA Drugs Across All Disease Indications

23-25 April, 2024 | Frankfurt, Germany

The 2nd mRNA Process Development & Manufacturing Summit Europe returns to reunite mRNA biopharma looking to innovate processes, speed up production and ensure the right balance is struck between quality of mRNA, efficacy of the final product, and the commercial opportunity in hand to unleash the full therapeutic value of mRNA across all disease indications. 

Hear from 20+ world-class industry speakers pioneering the mRNA space in Europe, including BioNTech, MHRA, CureVac, Sanofi and more. Join us in Frankfurt this April to explore key bottlenecks from mRNA sequence design, in vitro transcription, purification, scale up and mRNA drug product development to accelerate your processes and develop safe, potent and effective mRNA drugs for infectious disease, oncology and beyond. 

Join 100+ Directors, Heads and Senior Scientists of Upstream and Downstream Process Development, Analytical Development, CMC, Manufacturing and Drug Product to spur the rate of innovation, set necessary frameworks and forge meaningful partnerships to meet critical process, scale and regulatory needs that are currently preventing the mRNA community from fully realising the therapeutic and commercial opportunities offered by this disruptive class of drugs.  

MHRA Sponsor Logo

"The value in taking part at this meeting is in the sharing of knowledge and regulatory understanding by the MHRA to help develop of new medicines for patients in the UK.” 

Francis Galaway

Quality Assessor, MHRA 

A Snapshot of the Speaker Faculty:

Snapshot of Confirmed Partners:

Who's Attending in April?